ISL
NSPR icon

Ingalls & Snyder LLC’s InspireMD NSPR Stock Holding History

Ingalls & Snyder LLC’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$618K Sell
379,300
-5,000
-1% -$8.53K 0.02% 260
2025
Q4 		$684K Buy
384,300
+159,298
+71% +$332K 0.03% 253
2025
Q3 		$542K Buy
+225,002
New +$546K 0.02% 290

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
AF
Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return

Ingalls & Snyder LLC's NSPR Position: Q1 2026 in Review

Ingalls & Snyder LLC reduced its InspireMD (NSPR) stake by 1.3% in Q1 2026, selling an estimated $8.53K and leaving 379,300 shares worth $618K. The position accounts for 0.02% of the portfolio, ranked #260.

Ingalls & Snyder LLC first reported a position in NSPR in Q3 2025 and has held it in 3 quarters since. The position peaked at $684K in Q4 2025. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

  • Ingalls & Snyder LLC held 379,300 shares of InspireMD worth $618K as of Q1 2026.
  • Ingalls & Snyder LLC sold 5,000 InspireMD shares in Q1 2026, an estimated $8.53K.
  • InspireMD made up 0.02% of Ingalls & Snyder LLC's portfolio in Q1 2026, its #260 holding.
  • Ingalls & Snyder LLC first reported a position in InspireMD in Q3 2025 and has held it in 3 quarters since.
  • Ingalls & Snyder LLC's InspireMD position peaked at $684K in Q4 2025.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.